BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kočárová R, Horáček J, Carhart-Harris R. Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Front Psychiatry 2021;12:661233. [PMID: 34349678 DOI: 10.3389/fpsyt.2021.661233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 de Meiroz Grilo MLP, Sousa GMD, Mendonça LACD, Lobão-soares B, Sousa MBCD, Palhano-fontes F, Araujo DBD, Perkins D, Hallak JEC, Galvão-coelho NL. Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior. Front Behav Neurosci 2022;16. [DOI: 10.3389/fnbeh.2022.901425] [Reference Citation Analysis]
2 Dourron HM, Strauss C, Hendricks PS, Barker E. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Pharmacol Rev 2022;74:982-1027. [DOI: 10.1124/pharmrev.121.000514] [Reference Citation Analysis]
3 Odland AU, Kristensen JL, Andreasen JT. Animal Behavior in Psychedelic Research. Pharmacol Rev 2022;74:1176-205. [PMID: 36180111 DOI: 10.1124/pharmrev.122.000590] [Reference Citation Analysis]
4 Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS. A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. CNS Drugs 2022. [PMID: 36097251 DOI: 10.1007/s40263-022-00944-y] [Reference Citation Analysis]
5 Holze F, Gasser P, Müller F, Dolder PC, Liechti ME. Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness A randomized, double-blind, placebo-controlled Phase II study. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.08.025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Devenot N, Conner T, Doyle R. Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative: A Manifesto for Psychonauts. Anthropol of Consciousness. [DOI: 10.1111/anoc.12154] [Reference Citation Analysis]
7 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Psychopharmacology (Berl) 2022. [PMID: 35939083 DOI: 10.1007/s00213-022-06187-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Brennan W, Belser AB. Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Front Psychol 2022;13:866018. [PMID: 35719571 DOI: 10.3389/fpsyg.2022.866018] [Reference Citation Analysis]
9 James E, Keppler J, L Robertshaw T, Sessa B. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol 2022;37:e2835. [PMID: 35175662 DOI: 10.1002/hup.2835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Vaid G, Walker B. Psychedelic Psychotherapy: Building Wholeness Through Connection. Glob Adv Health Med 2022;11:2164957X221081113. [PMID: 35223197 DOI: 10.1177/2164957X221081113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kesner L, Horáček J. Global Adversities, the Media, and Mental Health. Front Psychiatry 2021;12:809239. [PMID: 35082704 DOI: 10.3389/fpsyt.2021.809239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. Psychedelic medicines for mood disorders: current evidence and clinical considerations. Curr Opin Psychiatry 2022;35:22-9. [PMID: 34855694 DOI: 10.1097/YCO.0000000000000759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
13 Pearson C, Siegel J, Gold JA. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. J Neurol Sci 2021;434:120096. [PMID: 34942586 DOI: 10.1016/j.jns.2021.120096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Saeger HN, Olson DE. Psychedelic-inspired approaches for treating neurodegenerative disorders. J Neurochem 2021. [PMID: 34816433 DOI: 10.1111/jnc.15544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]